Brief: Steven Cohen Reports 9.9% Passive Stake In Corvus Pharmaceuticals Inc As Of May 2
May 9 (Reuters) -
Steven Cohen:
* STEVEN COHEN REPORTS 9.9% PASSIVE STAKE IN CORVUS
PHARMACEUTICALS INC AS OF MAY 2 - SEC FILING
Source text for Eikon: ID:n0000902664-24-003432
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Corvus Pharmaceuticals
See all newsBrief: Corvus Pharmaceuticals Announces Initiation Of Phase 1B Clinical Trial Of Soquelitinib For Patients With Hidradenitis Suppurativa
Corvus Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj
U.S. STOCKS ON THE MOVE-Toll Brothers, TG Therapeutics, CECO Environmental